Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · IEX Real-Time Price · USD
7.16
-0.30 (-4.02%)
At close: Jul 2, 2024, 4:00 PM
7.18
+0.02 (0.28%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.92 billion as of July 2, 2024. Its market cap has increased by 35.68% in one year.
Market Cap
1.92B
Enterprise Value
1.67B
1-Year Change
35.68%
Ranking
Category
Stock Price
$7.16
Market Cap Chart
Since the IPO on April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $2.92B to $1.92B, a decrease of -34.19%. That is a compound annual growth rate of -12.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.77B | -16.99% |
| Dec 29, 2023 | 2.14B | 46.14% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -0.82% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 1.78B |
| Arvinas | 1.78B |
| Ardelyx | 1.77B |
| Harmony Biosciences Holdings | 1.73B |
| Evotec SE | 1.72B |
| Zai Lab | 1.71B |
| National HealthCare | 1.69B |
| Galapagos NV | 1.65B |